Climate Change Data

Galapagos NV

Climate Impact & Sustainability Data (2018, 2020, 2021, 2022, 2023)

Reporting Period: 2018

Environmental Metrics

ESG Focus Areas

  • Improving people’s lives
  • Business ethics
  • Diversity and human capital management
  • Environment, health, and safety

Environmental Achievements

  • Decommissioned one radio-isotope laboratory in Mechelen, replacing it with fluorescence and luminescence-based technologies, reducing toxic and dangerous waste flows.
  • Rolled out company-wide Skype video meetings to reduce business travel.

Social Achievements

  • Attracted 125 new employees (21% increase from 2017).
  • Maintained a healthy balance in workforce diversity, with 61% female staff overall.
  • Over 10% of internal R&D staff experienced personal growth through promotion or new assignments.
  • Raised EUR 27,578 for charity.
  • Implemented a new travel policy.
  • Strengthened the human resources team to build an innovative workplace strategy.
  • Streamlined the onboarding process, including assigning mentors to new employees.
  • Implemented a focus on four core values (Act as a pioneer, Raise the bar, Embrace change, and Make it happen) in recruiting, onboarding, and development programs.

Governance Achievements

  • Formalized clinical trials ethics policy.
  • Established a compassionate use policy.
  • Trained 93% of employees in codes of conduct (including insider trading) and Sarbanes-Oxley requirements.
  • Completed an Animal Welfare Agency audit with no citations.
  • Completed environmental audits in Leiden and Mechelen with no major citations.
  • Completed compliance reviews for health and safety and environment in Leiden, Mechelen, and Romainville sites, implementing improvement action plans.

Climate Goals & Targets

Long-term Goals:
  • Make employees more aware of limiting environmental impact.
  • Use fewer radio-isotopes.
  • Establish further EHS KPIs for internal monitoring and external reporting.
Medium-term Goals:
  • Investigate expanding green energy use to other sites.
Short-term Goals:
  • Expand capabilities to support more than 40 planned clinical trials in 2019.
  • Continue to deliver on annual R&D ambition targets.
  • Invest in target discovery capabilities.
  • Deploy a senior leader-led program to foster culture and build leadership capability.
  • Continue to incorporate core values into attracting, onboarding, and developing employees.
  • Revisit performance management approach.
  • Promote the 3Rs further in preclinical testing.
  • Monitor and adjust training to ensure full compliance with business ethics guidelines.
  • Organize exclusive use of green energy at Mechelen site starting in 2019.
  • Establish green car options in company car fleet starting in 2019.

Environmental Challenges

  • Limited environmental impact due to lack of production sites and buildings.
  • Need to further reduce environmental impact and improve EHS efforts.
Mitigation Strategies
  • Hired a full-time EHS Manager to assess current efforts and establish an improvement roadmap.
  • Established a company-wide EHS framework based on ISO 45001 and ISO 14001.
  • Implemented actions to address improvement items identified in compliance reviews.
  • Planned to establish green car options and exclusive use of green energy at Mechelen site in 2019.

Supply Chain Management

Responsible Procurement
  • Suppliers required to adhere to contractual terms including anti-bribery and anti-corruption provisions.

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: GRI Sustainability Reporting Standards (SRS), European Federation of Financial Analysts Societies Guideline for the Integration of ESG into Financial Analysis and Corporate Valuation

Reporting Period: 2020

Environmental Metrics

ESG Focus Areas

  • Improving people’s lives
  • Our employees
  • Conducting business ethically and responsibly
  • We care about the environment, health and safety

Environmental Achievements

  • Installed beehives on the roof of our building in Mechelen
  • Improved recycling of electric and electronic laboratory waste material at our site in Romainville
  • Improved chemical safety by the implementation of software to support risk assessments for dangerous chemicals at our site in Leiden
  • Reduced paper usage through digitalization

Social Achievements

  • Attracted 504 new employees in 2020, 58% of the hires were female
  • Improved talent-scouting model during COVID-19
  • Sharpened, digitized, and branded the Galapagos career site
  • Made onboarding approach and program more efficient
  • Implemented engagement initiatives to create team-cohesion and strengthen the feeling of belonging
  • Engaged with local communities and charities through a “We Care” initiative
  • Promoted a career in science through STEM initiatives
  • 2.2% turnover of employees for the Galapagos group

Governance Achievements

  • Implemented an Animal Welfare Committee
  • 93.5% of employees completed training on Code of Business Conduct and Ethics
  • Strengthened EHS Governance Structure and expert skills

Climate Goals & Targets

Long-term Goals:
  • Bring innovation to patients suffering from severe diseases
Medium-term Goals:
  • Maintain an active portfolio of 30 projects
  • Extend commercial reach with filgotinib in Europe
  • Further strengthen the Galapagos Compliance & Ethics Program
Short-term Goals:
  • Execute on a workplace strategy, building on the “To The Next Normal” program
  • Improve employer branding position
  • Boost cross-department mobilization of talents
  • Refine internal talent pipelines and succession plans

Environmental Challenges

  • COVID-19 pandemic impact on R&D efforts and operations
  • Maintaining a safe work environment during the pandemic
Mitigation Strategies
  • Provided additional electronics to facilitate working from home
  • Organized online mindfulness moments
  • Paid a stipend to cover additional home costs
  • Coordinated “license to work” conditions during the COVID-19 pandemic by performing risk analysis and defining safe conditions to work on site as well as from home

Supply Chain Management

Responsible Procurement
  • CSR criteria in vendor selection
  • Anti-bribery and anti-corruption provisions in contracts

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: Sustainable Development Goals (SDGs)

Certifications: ISO 14001, ISO 45001

UN Sustainable Development Goals

  • Good health and well-being
  • Quality education
  • Gender equality
  • Decent work and economic growth
  • Industry, innovation and infrastructure
  • Reduced inequalities
  • Climate action
  • Partnerships for the goals

The report links material aspects and engagement areas to selected aspects of the SDG framework.

Reporting Period: 2021

Environmental Metrics

ESG Focus Areas

  • Driving innovation
  • Our employees
  • Conducting business ethically and responsibly
  • We care about the environment, health, and safety

Environmental Achievements

  • Issued a global environmental, health and safety (EHS) policy
  • No fatalities because of work-related injuries or work-related ill-health were reported, nor were there any high-consequence work-related injuries.

Social Achievements

  • Improved candidate experience
  • Refined onboarding process
  • Launched GalapagosHealth.com, a hybrid engagement environment for healthcare professionals
  • Developed the Patient Partnership Charter
  • Celebrated International Day of Women and Girls in Science
  • Included in the 2022 Bloomberg Gender-Equality Index
  • Launched a digital challenge on social media to spark STEM with young people
  • Transformed annual Company Day into a cross-site 'We Care' initiative engaging with social and nature conservation organizations

Governance Achievements

  • Refined Code of Conduct
  • 93.5% of employees completed training on the new Code of Conduct
  • Launched the Galapagos Clinical Trials Portal
  • Redesigned Informed Consent template in accordance with Health Literacy principles

Climate Goals & Targets

Long-term Goals:
  • Define a long-term ambition, qualitative and quantitative objectives and an implementation roadmap focusing on optimizing employee health, safety, and well-being, promoting a circular mindset, and minimizing our carbon footprint throughout our value chain.
Medium-term Goals:
  • Invest in target discovery capabilities
  • Seek win-win collaborations to bolster the early-stage pipeline
  • Strengthen European commercial organization
Short-term Goals:
  • Set up the Galapagos Patient Engagement Council
  • Improve employer branding position via social media campaigns

Environmental Challenges

  • Pipeline setbacks leading to rightsizing of R&D and Shared Services departments
  • COVID-19 pandemic impacting operations and employee well-being
Mitigation Strategies
  • Invested in regular communication plans and Q&A sessions with senior leaders
  • Provided additional electronic equipment, online mindfulness sessions, and stipends to cover additional costs of working from home during the pandemic
  • Focused on enhancing employee performance and potential through development programs
  • Implemented global travel guidelines and guidance on organizing and attending internal and external events to mitigate pandemic risks

Supply Chain Management

Responsible Procurement
  • CSR criteria included in vendor selection process
  • Anti-bribery and anti-corruption provisions in contractual terms with suppliers

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: UN Sustainable Development Goals (SDGs)

UN Sustainable Development Goals

  • Good health and well-being
  • Partnerships for the goals
  • Quality education
  • Gender equality
  • Decent work and economic growth
  • Industry, innovation and infrastructure
  • Reduced inequalities
  • Climate action

Material aspects linked to selected SDGs

Awards & Recognition

  • 2022 Bloomberg Gender-Equality Index

Reporting Period: 2022

Environmental Metrics

ESG Focus Areas

  • Patients
  • People
  • Planet
  • Trust & Transparency

Environmental Achievements

  • Obtained BREEAM Excellent and WELL Gold certification for new building in Oegstgeest, Netherlands.
  • Defined carbon footprint of value chain (to be disclosed in 2023).
  • Defined roadmap to become climate neutral by 2028.

Social Achievements

  • Launched "Make it Happiness" global wellbeing program.
  • No fatalities or high-consequence work-related injuries reported.
  • Included in the 2023 Bloomberg Gender-Equality Index for the fourth year in a row.
  • Overall wellbeing met or exceeded Belgian benchmark in majority of questions in employee survey.

Governance Achievements

  • Established a Sustainability Steering Committee.
  • 97.1% of employees completed Code of Conduct training.
  • Launched Speak Up, Listen Up program.
  • Launched anti-harassment and anti-discrimination policy (to be implemented in 2023).

Climate Goals & Targets

Medium-term Goals:
  • Become carbon neutral by 2028.
Short-term Goals:
  • Identify KPIs and set targets to reach 2028 call for action.

Environmental Challenges

  • Reducing greenhouse gas emissions.
  • Becoming climate neutral by 2028.
Mitigation Strategies
  • Implementing initiatives to replace fossil fuels with renewable energy sources, improve energy efficiency, and drive behavioral change.

Supply Chain Management

Responsible Procurement
  • Enhanced risk assessment framework and due diligence on quality, IT security, data protection and privacy, compliance and ethics, and environment.

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: UN Sustainable Development Goals (SDGs), Corporate Sustainability Reporting Directive (CSRD)

Certifications: ISO 14001, ISO 45001, BREEAM, WELL

UN Sustainable Development Goals

  • Good Health and Well-being
  • Quality Education
  • Gender Equality
  • Decent Work and Economic Growth
  • Industry, Innovation and Infrastructure
  • Reduced Inequalities
  • Climate Action

The report links material aspects and engagement areas to selected aspects of the SDG framework.

Awards & Recognition

  • Bloomberg Gender-Equality Index

Reporting Period: 2023

Environmental Metrics

Total Carbon Emissions:40,591 tCO2e (location-based) / 39,632 tCO2e (market-based)
Scope 1 Emissions:2,922 tCO2e
Scope 2 Emissions:1,132 tCO2e (location-based) / 173 tCO2e (market-based)
Scope 3 Emissions:36,537 tCO2e
Renewable Energy Share:25%
Total Energy Consumption:18,687 MWh

ESG Focus Areas

  • Patients
  • People
  • Planet
  • Trust & Transparency

Environmental Achievements

  • Launched a new mobility strategy aimed at accelerating the electrification of our car fleet and offering alternative transportation modes. In Belgium, all new fleet vehicles must be fully electric as of 1 May 2024.
  • 25% of total energy needs covered by renewable sources in 2023.
  • 23% of the heated surface used by Galapagos was BREEAM or WELL certified.

Social Achievements

  • Completed the integration of the CellPoint and AboundBio teams into Galapagos with a robust onboarding program.
  • Included in the 2023 Bloomberg Gender-Equality Index for the fourth year in a row.
  • Rolled out a new initiative of “Team Boosters, ” offsite team development sessions to boost engagement and belonging.
  • Galapagos employees and leaders attended more than 4,500 Galapagos learning and development events (excluding Compliance training, conferences and on-the-job learning).
  • Enhanced employee offerings at both the international and country level (expanded information about total rewards, stock-based awards, improved local benefits).

Governance Achievements

  • Launched a Speak up, Listen Up program.
  • Launched an anti-harassment and anti-discrimination policy.
  • 94% of employees completed Code of Conduct training.
  • Third-Party Risk Assessment (TPRA) process for onboarding new vendors is mandatory.
  • External screening of 100 preferred suppliers, checking different risk factors, including ESG indicators.

Climate Goals & Targets

Medium-term Goals:
  • Become climate neutral by 2028.
Short-term Goals:
  • Update double materiality assessment to reflect impact of Jyseleca® transfer.

Environmental Challenges

  • Significant change and continued transformation for Galapagos impacting employees.
  • Transfer of Jyseleca® business to Alfasigma, including approximately 400 Galapagos positions.
  • Restructuring affecting 100 positions across European sites.
  • Three animal welfare incidents identified.
Mitigation Strategies
  • Company-wide survey to understand the impact of changes on company values and culture.
  • Robust onboarding program for integrating new teams.
  • Investigation of animal welfare incidents and implementation of remediation measures.
  • On-site visits planned to verify effectiveness of implemented actions.

Supply Chain Management

Supplier Audits: Regular audits of GxP manufacturers and distributors; External screening of 100 preferred suppliers.

Responsible Procurement
  • Enhanced risk assessment framework and due diligence on quality, IT security, data protection and privacy, compliance and ethics, and environment for third-party onboarding.

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: UN Sustainable Development Goals (SDGs), UN Global Compact, EU Taxonomy Regulation, EU Sustainability Reporting Standards (ESRS)

Certifications: ISO 14001, ISO 45001

UN Sustainable Development Goals

  • SDG 3: Good health and well-being
  • SDG 17: Partnerships for the goals
  • SDG 4: Quality education
  • SDG 5: Gender equality
  • SDG 8: Decent work and economic growth
  • SDG 9: Industry, innovation and infrastructure
  • SDG 10: Reduced inequalities
  • SDG 13: Climate action

Galapagos links its material aspects and engagement areas to select components of the SDG framework.

Awards & Recognition

  • Bloomberg Gender-Equality Index